These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27358215)

  • 81. Calcineurin and mTOR Inhibitor-Free Post-Transplantation Cyclophosphamide and Bortezomib Combination for Graft-versus-Host Disease Prevention after Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I/II Study.
    Al-Homsi AS; Cole K; Muilenburg M; Goodyke A; Abidi M; Duffner U; Williams S; Parker J; Abdel-Mageed A
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1651-1657. PubMed ID: 28549771
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dermatoscopy of Grover's disease and solitary acantholytic dyskeratoma shows a brown, star-like pattern.
    Giacomel J; Zalaudek I; Argenziano G
    Australas J Dermatol; 2012 Nov; 53(4):315-6. PubMed ID: 23157785
    [No Abstract]   [Full Text] [Related]  

  • 85. Drug-induced Grover's disease: a case report and review of the literature.
    Awe O; Pavlidakey P; Kole L; Kissel R
    Int J Dermatol; 2022 May; 61(5):591-594. PubMed ID: 34302358
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Management and Treatment of Grover's Disease: A Case Report and Review of Literature.
    Sousou JM; Fritsche JM; Fernandez BR; Tummala MR; Scott R
    Cureus; 2022 Apr; 14(4):e24082. PubMed ID: 35573509
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quantum optical implementation of Grover's algorithm.
    Scully MO; Zubairy MS
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9490-3. PubMed ID: 11504938
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Grover's Disease in a Liver Transplant Patient.
    Moon HR; Lee JH; Rhee DY; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Ann Dermatol; 2014 Feb; 26(1):117-8. PubMed ID: 24648700
    [No Abstract]   [Full Text] [Related]  

  • 89. Grover disease associated with docetaxel chemotherapy.
    Afvari S; Chiu MW
    JAAD Case Rep; 2022 Nov; 29():86-88. PubMed ID: 36199674
    [No Abstract]   [Full Text] [Related]  

  • 90. Atypical form of transient acantholytic dermatosis with edematous erythema.
    Yanagida N; Morioke S; Murakami E; Tanaka A
    Dermatol Reports; 2023 Dec; 15(4):9701. PubMed ID: 38327587
    [No Abstract]   [Full Text] [Related]  

  • 91. Dermoscopic clues to diagnose acantholytic dyskeratosis.
    Specchio F; Argenziano G; Tiodorovic-Zivkovic D; Moscarella E; Lallas A; Zalaudek I; Longo C
    Dermatol Pract Concept; 2015 Jan; 5(1):59-60. PubMed ID: 25692085
    [No Abstract]   [Full Text] [Related]  

  • 92. Dermoscopic View of Papular Acantholytic Dyskeratosis of the Genitocrural Region.
    Cebeci D; Can İ; Kobat İ
    Dermatol Pract Concept; 2022 Jul; 12(3):e2022084. PubMed ID: 36159118
    [No Abstract]   [Full Text] [Related]  

  • 93. Treatment of transient acantholytic dermatosis with liquid nitrogen.
    Galamgam J; Lee DJ
    JAAD Case Rep; 2020 Apr; 6(4):341-343. PubMed ID: 32258316
    [No Abstract]   [Full Text] [Related]  

  • 94. Papular Acantholytic Dyskeratosis of the Inguinal Area in a 49-Year-Old Man.
    Lee HS; Kim YC
    Ann Dermatol; 2017 Jun; 29(3):363-364. PubMed ID: 28566921
    [No Abstract]   [Full Text] [Related]  

  • 95. Incidental focal acantholytic dyskeratosis in the setting of rosacea.
    Park SY; Lee HJ; Shin JY; Ahn SK
    Ann Dermatol; 2013 Nov; 25(4):518-20. PubMed ID: 24371411
    [No Abstract]   [Full Text] [Related]  

  • 96. Spontaneous Regression of Papular Acantholytic Dyskeratosis of Genitocrural Area: A Case Report with Positive DIF Findings.
    Jiang X; Zhu T
    Indian J Dermatol; 2020; 65(5):437-438. PubMed ID: 33165405
    [No Abstract]   [Full Text] [Related]  

  • 97. Dermoscopy: A Valuable Tool in the Diagnosis of Flexural Acantholytic Dyskeratosis Disorders.
    Rajamohanan RR; Srinivas BH; Behera B
    Indian Dermatol Online J; 2022; 13(1):163-164. PubMed ID: 35198498
    [No Abstract]   [Full Text] [Related]  

  • 98. Transient Acantholytic Dermatosis: New Dermatoscopic Features.
    Mansur AT; Demirkesen C
    Indian J Dermatol; 2021; 66(6):683-685. PubMed ID: 35283516
    [No Abstract]   [Full Text] [Related]  

  • 99. Acantholytic PRIDE syndrome.
    Behera B; Nayak AK; Dash S; Sethy M; Ayyanar P
    J Cutan Pathol; 2024 Jul; ():. PubMed ID: 38987224
    [No Abstract]   [Full Text] [Related]  

  • 100. Transient acantholytic dyskeratosis (Grover's disease) after bone marrow transplantation.
    Lim PPL; Fernandez Penas P; Gottlieb D
    Australas J Dermatol; 2016 Nov; 57(4):e120-e122. PubMed ID: 27358215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.